BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 830419)

  • 1. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
    Krueger JG; Segal RA; Moyer RC
    Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the electrophoretic mobility of thymus, spleen and lymph node cells in tumor-bearing mice during dynamic tumor growth].
    Grinevich IuA; Fil'chakov FV; Alekseev SB; Kuz'menko AP
    Tsitologiia; 1989 Feb; 31(2):209-14. PubMed ID: 2734850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enumeration of polyclonal mitogen-responsive cells in different lymphoid tissues of the mouse.
    Doenhoff MJ; Janossy G; Kerbel RS
    Immunology; 1976 Mar; 30(3):367-78. PubMed ID: 1082851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the mitogen response of lymphoid cells with progressive tumor growth.
    Gillette RW; Boone CW
    Cancer Res; 1975 Dec; 35(12):3774-9. PubMed ID: 1081429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
    Boyer PJ; Fahey JL
    Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
    Watson GA; Lopez DM
    J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of normal T lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E
    Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific lymphocyte proliferative responses in inbred mice after Trichinella spiralis infection.
    Zhu DZ; Lu XF; Bell RG
    J Parasitol; 1990 Feb; 76(1):85-92. PubMed ID: 1688939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll.
    Goud SN; Muthusamy N; Subbarao B
    J Immunol; 1988 May; 140(9):2925-30. PubMed ID: 3129503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential function of dendritic cells isolated from blood and lymph nodes.
    Hill S; Coates JP; Kimber I; Knight SC
    Immunology; 1994 Oct; 83(2):295-301. PubMed ID: 7835950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.